Research program includes clinical and basic science approaches to study the effects of cigarette smoke on lung inflammation. He is also the Principal Investigator on the NIH-funded Spiromics Project and a Co-investigator on the COPD Clinical Research Network. Dr. Woodruff received his B.A, from Wesleyan University in 1989, received his M.D. degree from the Columbia College of Physicians and Surgeons in 1993, and completed Internal Medicine residency training at the Massachusetts General Hospital.
Dr. Sung is Professor of Health Economics at the Institute for Health & Aging at UCSF. Her tobacco-related research areas focus on 1) estimating the healthcare costs of cigarette smoking, other tobacco use, and secondhand smoke exposure; 2) economic evaluation of tobacco taxation, other tobacco control policies, and smoking cessation intervention programs; 3) economic impact of smoking on vulnerable populations such as African Americans, Hispanics, low-income people, and persons with mental illness; and 4) global health economics of tobacco use. Dr.
Dr. Smith's work focuses on tobacco control policy, particularly approaches to the tobacco endgame. Past projects include work on the tobacco industry's influence on and relationships with the lesbian, gay, bisexual and transgender communities, tobacco industry interest in diet and obesity issues, tobacco product waste and pollution, and tobacco control policy issues in the U.S. military.
Dr. Danielle Ramo is Associate Professor in Residence and licensed psychologist in the Department of Psychiatry and the Helen Diller Family Comprehensive Cancer Center at UCSF. She directs the Research on Addictions and Digital Interventions lab (readi.ucsf.edu), and co-directs the Psychiatry Digital Health Core (http://psychdhc.ucsf.edu). Her research program focuses on using digital media to understand and address risky drug and alcohol use. Dr.
Dr. Nguyen is the Stephen J. McPhee, MD Endowed Chair in General Internal Medicine and Professor of Medicine at the University of California, San Francisco (UCSF). A general internist with a panel of diverse patients, Dr. Nguyen teaches medical students and residents about medicine, health equity, and community-based participatory research (CBPR).
Research focuses on tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use. Dr. Malone is known nationally and internationally for her research on the tobacco industry’s strategic efforts to counter public health. Her work is funded by the National Cancer Institute, NIH, and by the California Tobacco-Related Disease Research Program. She has served as a consultant on tobacco industry activities for the U.S.
Research program involves estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws. Dr. Lightwood has done research in cost-benefit and cost-effectiveness analysis of disease prevention and management programs, cost savings attributable to smoking cessation, and the economics of infectious disease control
Dr. Susan M.Lee recently completed a trial investigating a smoking cessation program implemented preoperatively, through which she gained an understanding of the challenges of implementing a multidisciplinary program and techniques to overcome these challenges. She has since successfully established strong ties with community agencies, such as the Smokers' Helpline, and collaborated with other researchers, culminating in a peer-reviewed publication and implementation of the program clinically.
Associate Vice Chancellor, Clinical and Translational Science Institute
Dr. Jennifer R. Grandis received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr. Grandis was the UPMC Endowed Chair in Head and Neck Cancer Surgical Research and Distinguished Professor of Otolaryngology and Pharmacology and Chemical Biology at the University of Pittsburgh.
Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research. He has focused on understanding key elements of human atherosclerosis including the pathobiology of the human endothelium, the biology of vascular nitric oxide, systemic and vascular inflammatory responses and atherosclerotic plaque instability.
